Primary prevention of breast cancer: New approaches

Maturitas

Volumn 57, Issue 1, 2007, Pages 39-41

  Cummings, Steven R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Mammogram; Raloxifene; Tamoxifen

Indexed keywords

AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; ESTRADIOL; RALOXIFENE; TAMOXIFEN;

ALCOHOL ABSTINENCE; ARTHRALGIA; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER RISK; CATARACT; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM CANCER; EXERCISE; FLUSHING; FRACTURE; HUMAN; LIFESTYLE MODIFICATION; MAMMOGRAPHY; OSTEOLYSIS; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; VENOUS THROMBOEMBOLISM; VERTEBRA FRACTURE; WEIGHT REDUCTION;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; LIFE STYLE; MAMMOGRAPHY; RALOXIFENE; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 34247097829     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.02.010     Document Type: Article

References (21)

1. McTiernan A., Kooperberg C., White E., et al. Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA 290 10 (2003) 1331-1336
2. Eliassen A.H., Colditz G.A., Rosner B., Willett W.C., and Hankinson S.E. Adult Weight Change and Risk of Postmenopausal Breast Cancer 10.1001/jama.296.2.193. JAMA 296 2 (2006) 193-201
3. Smith-Warner S.A., Spiegelman D., Yaun S.S., et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 279 7 (1998) 535-540
4. Tjonneland A., Christensen J., Olsen A., et al. Folate intake, alcohol and risk of breast cancer among postmenopausal women in Denmark. Eur J Clin Nutr 60 2 (2006) 280-286
5. Baglietto L., English D.R., Gertig D.M., Hopper J.L., and Giles G.G. Does dietary folate intake modify effect of alcohol consumption on breast cancer risk? Prospective cohort study. BMJ 331 7520 (2005) 807
6. Prentice R.L., Caan B., Chlebowski R.T., et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295 6 (2006) 629-642
7. Smith-Warner S.A., Spiegelman D., Yaun S.S., et al. Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA 285 6 (2001) 769-776
8. Malin A.S., Qi D., Shu X.O., et al. Intake of fruits, vegetables and selected micronutrients in relation to the risk of breast cancer. Int J Cancer 105 3 (2003) 413-418
9. Fisher B., Dignam J., Wolmark N., et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353 9169 (1999) 1993-2000
10. Barrett-Connor E., Mosca L., Collins P., et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 355 2 (2006) 125-137
11. Cummings S.R., Eckert S., Krueger K.A., et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 281 23 (1999) 2189-2197
12. Vogel V.G., Costantino J.P., Wickerham D.L., et al. Effects of tamoxifen vs. raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA 295 23 (2006) 2727-2741
13. Ettinger B., Black D.M., Mitlak B.H., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282 7 (1999) 637-645
14. Smith I.E., and Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med. 24 (2003) 2431-2442
15. Mauri D., Pavlidis N., Polyzos N.P., and Ioannidis J.P. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. J Natl Cancer Inst 98 18 (2006) 1285-1291
16. Eastell R., and Hannon R. Long-term effects of aromatase inhibitors on bone. J Steroid Biochem Mol Biol 95 1-5 (2005) 151-154
17. Rockhill B., Spiegelman D., Byrne C., Hunter D.J., and Colditz G.A. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93 5 (2001) 358-366
18. Boyd N.F., Rommens J.M., Vogt K., et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6 10 (2005) 798-808
19. McCormack V.A., and Dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15 6 (2006) 1159-1169
20. Barlow W.E., White E., Ballard-Barbash R., et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 98 17 (2006) 1204-1214
21. US Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002;137(6):526-8.